Back

No impact of direct implantation of a self-expanding valve on one-year clinical outcomes. Insights from the multicenter, randomized DIRECT trial.

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Interventional Cardiology ePosters Aortic Valve Intervention ESC Premium Access ESC Congress 2020

About the speaker

Photo
Professor Konstantinos Toutouzas

National & Kapodistrian University of Athens, Athens (Greece)

174 More presentations in this session

Presentation thumbnail
Clinical profile and predictors of positivity of acetylcholine test in patients with angina and no obstructive coronary artery disease. Results of a multi-center mediterranean registry.
Doctor L. Grigorian (Madrid, ES)
Abstract Slides
Presentation thumbnail
Comparison of neointimal coverage between biodegradable-polymer everolimus-eluting stent and durable-polymer everolimus-eluting stent using angioscopy for the patients with acute coronary syndrome
Assistant Professor T. Umemoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Global risk factors of contrast-Induced acute kidney injury: systematic review and meta-analysis
Doctor L. Liu (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Post-procedural quantitative flow ratio gradient and target lesion revascularization after drug-coated balloon or plain-old balloon angioplasty
Doctor H. Kirigaya (Yokohama, JP)
Abstract Slides
Presentation thumbnail
Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pressure pullbacks gradients (PPG) index.
Doctor A. Candreva (Zurich, CH)
Abstract Slides

Access the full session

Session thumbnail
Interventional Cardiology ePosters

The Event

Event poster

ESC Congress 2020

28 August 2020 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Echocardiographic assessment of functional changes of prosthetic valve after transcatheter aortic valve implantation in one year follow up: Insights from the multicenter, randomized DIRECT trial.
28 August 2020
thumbnail
Congress Session
Breaking boundaries in PCI: how is the SELUTION DeNovo trial impacting your PCI practice?
19 February 2026
thumbnail
Congress Presentation
Comparative risk of permanent pacemaker implantation in SAVR with sutureless valve prosthesis versus TAVI
13 June 2025
thumbnail
Congress Presentation
Real-world comparison of the last generation balloon-expandable and self-expanding valves in patients undergoing TAVI.
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources